Energy Balance and Weight Gain With Ivacaftor Treatment of CFTR Gating Mutations
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 17 Jul 2017 Status changed from active, no longer recruiting to completed.
- 16 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.
- 07 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Jan 2017.